Delivery Order SPE2DB20D1109-SPE2DB25FP32X
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$35K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has a firm fixed price of $7,905.73 and an ultimate completion date of July 2, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract is not set aside for any specific business type....
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $3,920.01 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 23, 2025 with a completion date of June 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $18,726.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 28, 2024 and is a Firm Fixed Price Delivery Order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $1,153.40 and an ultimate completion date of April 23, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,808.93 and an ultimate completion date of February 15, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $16,170.49 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 18, 2024, with a completion date of January 19, 2024. The contract is a delivery order and is priced as a firm fixed price. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 11, 2025, with a ceiling value of $19,855.67 and a completion date of March 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,464.00 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order and has a firm fixed price pricing type. The award does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a ceiling value of $3,453.16 and a completion date of June 11, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,084.92, and has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a...